HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Somaderm 'FDA Registered' But Not 'Approved' – Similac-Enfamil Comparison Also Reviewed

Executive Summary

Similac marketer Abbott Nutrition supports most but not all ad claims comparing its Human Milk Fortifier to Enfamil's; Council of Better Business Bureaus' investigative arms review claims comparing two baby probiotic drop brands and a protein digesting enzyme ad.

You may also be interested in...



Next Call Could Be Regulators After hGH Direct Seller Ignores Industry Self-Regulation Process

Direct seller New U Life may face regulatory scrutiny after two BBB National Programs, Inc. industry self-regulation programs reported it failed to stop using bogus health claims, including treating COVID-19.

Enfamil NeuroPro Ingredient Tests Miss, J&J Doubts Mommy's Bliss Claims

Council of Better Business Bureaus' industry self-regulation arm reviews claims for Mead Johnson's s Enfamil NeuroPro infant formula on challenge by Similac marketer Abbott Nutrition. Recent reviews also include ad claims for children's herbal remedies marketed by Mommy’s Blisson challenged by J&J's consumer business.

Industry Roundup: J&J Trims Splenda, Hearthside Boosts Capacity

Splenda in J&J’s past; Hearthside boosts bar capacity; speech supplement refunds; and more news in brief.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148571

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel